RU - Stichting Radboud Universiteit
Radboud University, located in Nijmegen, the Netherlands, aspires to make a significant impact through its research activities on regional, national, and international levels. Established in 1923, Radboud University has consistently been included in the top 150 of universities in the world by four major university ranking tables. The international, reputable research staff deliver top-quality research results, engage in multidisciplinary research initiatives, and develop novel approaches and innovations. The Faculty of Arts is committed to the development of knowledge with a strong scientific and social impact. With over 500 academic and support staff, we teach and conduct research in the fields of art, history, language, culture and communication, using innovative methodologies and collaborating closely across disciplines.
The Centre for Language Studies (CLS) is a research institute at Radboud University dedicated to the understanding of language and the way we use it. Our researchers study this fascinating topic from different perspectives and in several contexts, using a variety of innovative research methods. CLS aims to conduct research that is also valuable for organisations and audiences outside the academic world.
Role within PerPrev-CID
Radboud University is leader of two work packages in Cluster 8: WP16 on stakeholder engagement and involvement and WP18 on the effectiveness of communication strategies and the development of ethical, legal, and economic guidelines. In these roles, RU conducts patient-centred research and develops innovative communication strategies that address the complexities of risk assessment and low-threshold preventive interventions for rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). The approach involves integrating insights from literature reviews and interview studies to develop the materials as well as surveys to evaluate acceptance, knowledge, and willingness among patients, healthcare professionals, and other stakeholders. By engaging in iterative workshops and virtual round tables with patients and risk groups, RU ensures that patient perspectives are sufficiently researched and reflected. These efforts also emphasize patient autonomy, informed consent, and privacy rights, aiming to produce actionable policy recommendations, white papers, and communication tools that support ethically and economically sustainable early disease management.
